Elizabeth Arthur, MD
Dermatology · Rochester, NYNPI 1346219953
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,044 of the $13,044 with a category attached, or 61.7%. 28 manufacturers reported payments, led by AbbVie at 55.9% of the total. Reporting peaked in 2021 at $6,021 and has fallen 85.6% since, to $869 in 2025.
Across 473 payments — averaging $27.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Johnson & Johnson$571
- Sun Pharmaceutical Industries Inc.$560
- Pfizer$456
- Novartis$442
- Sanofi$414
- plus $3K from 22 others
What the payments were for
- Speaking & faculty fees$5,00038%
- Food & beverage$8,04462%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 146 | $7,288 |
| Johnson & Johnson | 23 | $571 |
| Sun Pharmaceutical Industries Inc. | 30 | $560 |
| Pfizer | 31 | $456 |
| Novartis | 25 | $442 |
| Sanofi | 14 | $414 |
| UCB, Inc. | 24 | $400 |
| Dermavant Sciences, Inc. | 52 | $384 |
| Lilly USA, LLC | 15 | $332 |
| Amgen | 12 | $324 |
| E.r. Squibb & Sons, L.L.C. | 14 | $305 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $298 |
| Galderma Laboratories, L.p. | 12 | $201 |
| Regeneron Healthcare Solutions, Inc. | 5 | $133 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $126 |
| LEO Pharma Inc. | 6 | $114 |
| Arcutis Biotherapeutics, Inc. | 6 | $114 |
| Incyte Corporation | 4 | $92 |
| Dermira, Inc. | 5 | $90 |
| Prugen, Inc. Pharmaceuticals | 20 | $71 |
| VYNE Pharmaceuticals Inc. | 3 | $51 |
| Mayne Pharma Commercial LLC | 3 | $50 |
| Bristol Myers Squibb | 2 | $48 |
| Sandoz | 2 | $43 |
| Strata Skin Sciences, Inc. | 4 | $39 |
| Biofrontera Inc. | 2 | $38 |
| DUSA Pharmaceuticals, Inc. | 2 | $36 |
| Almirall LLC | 1 | $23 |
How this compares
$13,044 in reported general payments places this provider in the 80th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 19 | $1,257 |
| Metronidazole | 18 | $1,002 |
| Clindamycin Phosphate | 17 | $897 |
| Clobetasol Propionate | 20 | $779 |
| Mometasone Furoate | 38 | $704 |
| ValacyclovirValacyclovir Hcl | 11 | $323 |
| Ketoconazole | 14 | $279 |
| Mupirocin | 19 | $142 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rochester
- Lisa BeckRochester$755K
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.